Cofactors and comorbidities in patients with aspirin/NSAID hypersensitivity
- PMID: 27865540
- DOI: 10.1016/j.aller.2016.08.010
Cofactors and comorbidities in patients with aspirin/NSAID hypersensitivity
Abstract
Hypersensitivity reactions to aspirin and other NSAIDs occur in individuals genetically predisposed and exhibit different clinical manifestations, especially respiratory, cutaneous, and generalised. Five different phenotypes define distinct clinical pictures: aspirin-exacerbated respiratory disease, aspirin/NSAID cutaneous disease, NSAID-induced urticaria, angio-oedema and anaphylaxis, single NSAID reactions, and delayed reactions. They are observed more frequently in middle-aged women, and in atopic individuals. While ASA/NSAID hypersensitivity shares comorbidities with asthma, chronic rhinosinusitis, nasal polyposis, chronic urticaria and angio-oedema, ASA and other NSAIDs can also be cofactors for other clinically relevant conditions, especially food-dependent exercise-induced anaphylaxis, angio-oedema induced by angiotensin-converting enzyme inhibitors, and oral mite anaphylaxis. Awareness on these relationships is required for the correct diagnosis, classification, and treatment of affected patients.
Keywords: Anaphylaxis; Angio-oedema; Aspirin; Asthma; Non-steroidal anti-inflammatory drugs; Rhinosinusitis; Urticaria.
Copyright © 2016 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.Curr Allergy Asthma Rep. 2015 Dec;15(12):69. doi: 10.1007/s11882-015-0569-2. Curr Allergy Asthma Rep. 2015. PMID: 26475526 Review.
-
New phenotypes in hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):302-307. doi: 10.1097/ACI.0000000000000541. Curr Opin Allergy Clin Immunol. 2019. PMID: 31107257 Review.
-
Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.Allergy Asthma Proc. 2015 Jan-Feb;36(1):34-9. doi: 10.2500/aap.2015.36.3800. Allergy Asthma Proc. 2015. PMID: 25562554 Review.
-
Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma.Allergol Immunopathol (Madr). 2015 Sep-Oct;43(5):442-8. doi: 10.1016/j.aller.2014.07.008. Epub 2014 Dec 26. Allergol Immunopathol (Madr). 2015. PMID: 25547458
-
Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma.Respir Med. 2013 Jul;107(7):967-74. doi: 10.1016/j.rmed.2013.03.014. Epub 2013 Apr 30. Respir Med. 2013. PMID: 23643317
Cited by
-
Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation.PLoS One. 2024 Feb 23;19(2):e0295791. doi: 10.1371/journal.pone.0295791. eCollection 2024. PLoS One. 2024. PMID: 38394074 Free PMC article.
-
Genetic Susceptibility of HLA Alleles to Non-Steroidal Anti-Inflammatory Drug Hypersensitivity in the Taiwanese Population.Biomedicines. 2023 Dec 11;11(12):3273. doi: 10.3390/biomedicines11123273. Biomedicines. 2023. PMID: 38137494 Free PMC article.
-
Pseudo-Allergies in the Emergency Department: A Common Misdiagnosis of Hypersensitivity Type 1 Allergic Reaction.Cureus. 2023 Oct 5;15(10):e46536. doi: 10.7759/cureus.46536. eCollection 2023 Oct. Cureus. 2023. PMID: 37927771 Free PMC article. Review.
-
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021. Front Immunol. 2021. PMID: 34305932 Free PMC article. Review.
-
A protocol for the development and internal validation of a model to predict clinical response to antihistamines in urticaria patients.PLoS One. 2020 Oct 6;15(10):e0239962. doi: 10.1371/journal.pone.0239962. eCollection 2020. PLoS One. 2020. PMID: 33022026 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
